New drug combo tested for Tough-to-Treat lung cancer
Disease control
Not yet recruiting
This study is testing a new two-drug combination (alisertib pills and paclitaxel infusions) for adults with small cell lung cancer that has continued to grow despite prior chemotherapy and immunotherapy. The main goal is to find the highest dose of alisertib that can be safely gi…
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC